Skip to content
    Back to Database
    Ergogenic CompoundsNatural

    Epicatechin

    Also known as: (-)-Epicatechin, epicatechin (a flavan-3-ol)

    Large trials and meta-analyses of flavan-3-ol interventions that include (-)-epicatechin show improved endothelial function and modest reductions in blood pressure, and a large randomized trial of cocoa extract containing 80 mg/day (-)-epicatechin did not reduce total cardiovascular events but lowered cardiovascular mortality in secondary analyses. Effects on other ageing biomarkers were not seen in a prespecified ancillary analysis.

    Last reviewed: 2026-10-14 · 3 indexed studies

    Evidence Score
    52/100
    Cardiovascular supportVascular endothelial functionGeneral antioxidant / polyphenol supplementation
    Data Completeness3/4 · 75%
    Evidence ScoreDosageSafetyLinked Studies

    Set your location for accurate regulatory status

    Saved on this device — no sign-in needed.

    Overview

    Epicatechin is a flavan-3-ol found in cocoa, tea and some fruits. Human trials have tested isolated cocoa flavanol supplements that contain a defined amount of (-)-epicatechin for effects on vascular outcomes and blood pressure.

    Mechanism & Function

    Mechanism of Action

    Clinical data point to improved endothelial function (increased flow-mediated dilation) and modest blood pressure lowering after chronic intake of flavan-3-ol–rich interventions; these vascular effects are the presumed mechanisms linking epicatechin-containing supplements to cardiovascular outcomes.

    Physiological Role

    Modulation of endothelial function and vascular tone; antioxidant and vasoactive effects as part of flavan-3-ol activity.

    Primary Pathways

    Endothelial function / nitric oxide–mediated vasodilationBlood pressure regulationAntioxidant / free radical modulation

    Performance / Health Relevance

    By improving endothelial function and lowering blood pressure modestly, epicatechin-containing supplements may influence cardiovascular health and related functional outcomes, though direct ergogenic effects on exercise performance are not established in the provided abstracts.

    Evidence Review

    Overall52/100
    Human Clinical43/100
    Meta-Analysis47/100
    Mechanistic70/100
    Real-World35/100
    Safety80/100

    Practical Use & Dosage

    Minimum Effective Dose
    80 mg/day (-)-epicatechin was used in large randomized trials (COSMOS).
    Optimal Range
    Not established from the provided abstracts; flavan-3-ol totals in meta-analysed interventions varied widely and dose–response with epicatechin was observed in cocoa studies.
    Upper / Caution Level
    Not established
    Timing
    Not established
    Best Format
    Cocoa extract or flavan-3-ol supplements standardised for flavanols/(-)-epicatechin
    Bioavailability
    Bioavailability of flavan-3-ols is variable and influenced by the food matrix and formulation.
    Absorption Considerations
    Chronic repetitive intake was the context for many observed vascular benefits; acute and chronic effects on endothelial function have both been reported in the literature synthesised by the meta-analysis.

    Safety & Interactions

    Side Effects

    • •Minor adverse events reported infrequently in trials (low overall rate in meta-analysis).

    Monitoring

    Monitor blood pressure when using for cardiovascular risk modification or alongside antihypertensive therapy.

    Frequently Asked Questions

    Auto-generated from indexed evidence — dosage, safety, interactions, and more.

    When is Epicatechin typically used or indicated?

    Epicatechin is most commonly used for: Cardiovascular support, Vascular endothelial function, General antioxidant / polyphenol supplementation. Modulation of endothelial function and vascular tone; antioxidant and vasoactive effects as part of flavan-3-ol activity.

    How does Epicatechin work?

    Clinical data point to improved endothelial function (increased flow-mediated dilation) and modest blood pressure lowering after chronic intake of flavan-3-ol–rich interventions; these vascular effects are the presumed mechanisms linking epicatechin-containing supplements to cardiovascular outcomes.

    What is the recommended dose of Epicatechin?

    The optimal range is Not established from the provided abstracts; flavan-3-ol totals in meta-analysed interventions varied widely and dose–response with epicatechin was observed in cocoa studies.. with a minimum effective dose of 80 mg/day (-)-epicatechin was used in large randomized trials (COSMOS).. Best taken: Not established. Upper / caution level: Not established.

    What are the side effects of Epicatechin?

    Reported side effects include: Minor adverse events reported infrequently in trials (low overall rate in meta-analysis).. Monitoring: Monitor blood pressure when using for cardiovascular risk modification or alongside antihypertensive therapy.

    How strong is the evidence for Epicatechin?

    Evidence level: Limited (overall score 52/100), based on 3 indexed studies on SuppIndex.

    Research & References (3)

    Effect of cocoa flavanol supplementation for the prevention of cardiovascular disease events: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial.

    RCT2022
    PubMed

    Large randomized, double-blind, placebo-controlled trial (COSMOS) tested cocoa extract providing 500 mg flavanols/day including 80 mg (-)-epicatechin versus placebo in 21,442 older adults over a median 3.6 years for prevention of cardiovascular events.

    Long-Term Effect of Cocoa Extract Supplementation on Incident Hypertension.

    RCT2025
    PubMed

    Prespecified analysis of COSMOS participants free of baseline hypertension examined incident hypertension with cocoa extract (500 mg flavanols/day including 80 mg (-)-epicatechin) versus placebo over median 3.4 years.

    Impact of flavan-3-ols on blood pressure and endothelial function in diverse populations: a systematic review and meta-analysis of randomized controlled trials.

    Meta-Analysis2025
    PubMed

    Systematic review and meta-analysis of 145 randomized controlled trials (109 publications, 5205 participants) of flavan-3-ol interventions (including epicatechin, cocoa, tea, grape and apple sources) assessing blood pressure and flow-mediated dilation.

    Related Ingredients

    Other top-rated ingredients in Ergogenic Compounds.

    Research Overview

    Limited Evidence
    3Total Studies
    2Human Trials
    1Meta-Analyses
    2025Latest Study
    0Animal / In Vitro
    0Athlete Studies
    Primary data sourceGeneral Population
    Pooled evidence (meta-analysis / systematic review)Yes

    Cite this ingredient

    One-click citation export in APA, MLA, Chicago, BibTeX, or HTML. The URL below is stable and safe to link.

    Stable URL

    https://thesuppindex.com/ingredients/epicatechin

    SuppIndex. (2026). Epicatechin: Evidence summary, dosage and clinical studies. Retrieved October 16, 2026, from https://thesuppindex.com/ingredients/epicatechin

    Based on 3 indexed studies · Evidence level: Limited.

    Goal Ratings

    General Health
    Metabolic Health

    Stack Compatibility

    Was tested together with a daily multivitamin in a factorial trial without safety concerns; typically combined with other dietary polyphenols or standard supplements.

    Multivitamin-mineral formulationsOther flavan-3-ol sources (tea, grape, apple extracts)